References
- Kasperska-Zajac A, Rogala B. Platelet function in anaphylaxis. J Invest Allergol Clin Immunnol 2006; 16: 1–4
- Kasperska-Zajac A, Rogala B. Platelet activation during allergic inflammation. Inflammation 2007; 30: 161–166
- Kasperska-Zajac A, Rogala B, Nowakowski M. Assessment of platelet activity, expressed by plasma levels of platelet factor 4 and beta-thromboglobulin in patients with chronic idiopathic urticaria. Exp Dermatol 2005; 14: 515–518
- Hilger RA, Neuber K, Konig W. Conversion of leukotriene A4 by neutrophils and platelets from patients with atopic dermatitis. Immunology 1991; 74: 689–695
- Neuber K, Hilger RA, König W. Differential increase in 12-HETE release and CD29/CD49f expression of platelets from normal donors and from patients with atopic dermatitis. Int Arch Allergy Immunol 1992; 98: 339–342
- Kasperska-Zajac A, Brzoza Z, Rogala B. Increased concentration of platelet-derived chemokines in serum of patients with delayed pressure urticaria. Eur Cytokine Netw 2008; 19: 89–91
- Kasperska-Zajac A, Brzoza Z, Rogala B. Platelet function in cutaenous diseases. Platelets 2008; 19: 317–321
- Kasperska-Zajac A, Rogala B. Markers of platelet activation in plasma of patients suffering from persistent allergic rhinitis with or without asthma symptoms. Clin Exp Allergy 2005; 35: 1462–1465
- Kasperska-Zając A, Rogala B. Platelet activity measured by plasma levels of beta-thromboglobulin and platelet factor 4 in seasonal allergic rhinitis during natural pollen exposure. Inflamm Res 2003; 52: 477–479
- Watanabe O, Natori K, Tamari M, Shiomoto Y, Kubo S, Nakamura Y. Significantly elevated expression of PF4 (platelet factor 4) and eotaxin in the NOA mouse, a model for atopic dermatitis. J Hum Genet 1999; 44: 173–176
- Bruijnzeel PL, Kuijper PH, Rihs S, Betz S, Warringa RA, Koenderman L. Eosinophil migration in atopic dermatitis. I: Increased migratory responses to N-formyl-methionyl-leucyl-phenylalanine, neutrophil-activating factor, platelet-activating factor, and platelet factor 4. J Invest Dermatol 1993; 100: 137–142
- Kasperska-Zajac A, Nowakowski M, Rogala B. Enhanced platelet activation in patients with atopic eczema/dermatitis syndrome. Inflammation 2004; 28: 299–302
- Tamagawa-Mineoka R, Katoh N, Ueda E, Masuda K, Kishimoto S. Elevated platelet activation in patients with atopic dermatitis and psoriasis: increased plasma levels of beta-thromboglobulin and platelet factor 4. Allergol Int 2008; 57: 391–396
- Rajka G, Lageland T. Grading of the severity of atopic dermatitis. Acta Derm Venereol 1989; 144(Suppl)13–14